Detalhe da pesquisa
1.
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
J Hepatol
; 73(1): 17-25, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147361
2.
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
Clin Gastroenterol Hepatol
; 18(1): 216-225.e5, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195161
3.
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).
J Hepatol
; 73(3): 740-741, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654856
4.
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
J Gastroenterol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619600